Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07455942 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Towards an Understanding of Barriers and Delays in the Diagnosis of Anal Cancer

Study acronym: FRACAS
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Recruitment opened
    • Trial sites expanded: 0 → 32 locations
    • Start date changed from estimate of Jun 30, 2026 to Jun 23, 2026
    v3
  2. Notable Start date: Mar 30, 2026 to Jun 30, 2026v2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study examines care pathways in 300 patients with anal squamous cell carcinoma to identify barriers and delays in diagnosis, assess the impact of screening and access to care, and improve awareness, screening practices, and early diagnosis.
Trial Details
NCT Number NCT07455942
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions
(from sponsor)
Squamous Cell Carcinoma of the Anal Canal, HPV-induced Cancer
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov